MAPT and Alzheimer disease: In addition, data also show that iNEU-PSEN cells are a reasonable alternative AD model to the transgenic mice to test strategies for attenuating Tau hyperphosphorylation and support the relevance of sustaining miR-124 expression levels within defined margins, as already proposed by other Authors [78].